Page last updated: 2024-10-31

metyrapone and Candidiasis, Oral

metyrapone has been researched along with Candidiasis, Oral in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Candidiasis, Oral: Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sherman, B1
Weinberger, M1
Chen-Walden, H1
Wendt, H1
Castells, S1
Inamdar, S1
Orti, E1

Trials

1 trial available for metyrapone and Candidiasis, Oral

ArticleYear
Further studies of the effects of inhaled glucocorticoids on pituitary-adrenal function in healthy adults.
    The Journal of allergy and clinical immunology, 1982, Volume: 69, Issue:2

    Topics: Administration, Intranasal; Adult; Beclomethasone; Candidiasis, Oral; Cortodoxone; Dose-Response Rel

1982

Other Studies

1 other study available for metyrapone and Candidiasis, Oral

ArticleYear
Familial moniliasis, defective delayed hypersensitivity, and adrenocorticotropic hormone deficiency.
    The Journal of pediatrics, 1971, Volume: 79, Issue:1

    Topics: 17-Ketosteroids; Addison Disease; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Child, Preschool

1971